Folate-conjugated chitosan/Zn-MOF for targeted 5-fluorouracil delivery in hepatocellular carcinoma

Key Points

• Targeted delivery of 5-fluorouracil shows significant improvement in cancer treatment efficacy.
• The folate-conjugated chitosan/zinc metal-organic framework successfully enhances drug delivery.
• Assessment of drug release rates indicates controlled and sustained release over time.
• Potential implications highlight the need for further testing in clinical settings.